BJDX
NASDAQ
$1.21
Bluejay Diagnostics Inc (BJDX)
Bluejay Diagnostics Inc. is an innovative medical technology company focused on revolutionizing patient care through its cutting-edge diagnostic solutions, with a strong emphasis on early disease detection. Utilizing a proprietary platform that combines advanced artificial intelligence with point-of-care testing, Bluejay enhances diagnostic accuracy and accelerates result delivery, thereby equipping healthcare providers with critical insights in real-time. The company is strategically poised to confront notable healthcare challenges and fulfill the growing demand for reliable and advanced diagnostic tools, leveraging its robust commitment to research and development in a rapidly evolving medical landscape.
Sector:
Healthcare
Industry:
Medical Devices
Target: $256 (+21057.02%)
Market Cap
$1.40M
P/B Ratio
0.31
Price Chart
Valuation
Market Cap$1.40M
P/S54.99
P/B0.31
Profitability
Total Revenue (TTM)$98K
Gross Profit (TTM)$49K
EBITDA-$6.92M
EPS-$13.36
Growth & Risk
Sharpe Ratio-0.22